<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharma on IT News</title>
    <link>https://it-news.uk/tags/pharma/</link>
    <description>Recent content in Pharma on IT News</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 01 Jul 2026 00:00:00 +0800</lastBuildDate>
    <atom:link href="https://it-news.uk/tags/pharma/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>18 of the top 20 pharma companies already use NVIDIA&#39;s BioNeMo. Now it connects to Claude Science.</title>
      <link>https://it-news.uk/posts/nvidia-bionemo-claude-science-pharma/</link>
      <pubDate>Wed, 01 Jul 2026 00:00:00 +0800</pubDate>
      <guid>https://it-news.uk/posts/nvidia-bionemo-claude-science-pharma/</guid>
      <description>&lt;p&gt;NVIDIA&amp;rsquo;s BioNeMo AI toolkit now plugs directly into Anthropic&amp;rsquo;s Claude Science workbench, the company announced Tuesday. The integration lets life science researchers describe tasks in natural language — analyze a genome sequence, predict a protein structure, design a potential drug candidate — and have AI agents route the work to NVIDIA&amp;rsquo;s accelerated computing stack.&lt;/p&gt;&#xA;&lt;p&gt;18 of the top 20 pharmaceutical companies are already using BioNeMo for drug discovery, genomics, medical imaging, molecular design, and protein engineering.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
